Beam Therapeutics CEO John M. Evans Reports Sale of $1.19 Million in Common Shares
Bitget2026/10/17 00:10- Beam Therapeutics CEO and director John M. Evans sold 50,000 common shares on October 15-16, 2026.
- Sales totaled 25,000 shares at $23.566 on October 15, with another 25,000 shares sold at $23.9838 on October 16.
- Evans exercised stock options for 25,000 common shares on each date at $1.03 per share.
- Direct common stock holdings stood at 1,047,205 shares following the transactions; indirect holdings totaled 103,000 shares through a trust.
- Remaining directly held stock options totaled 155,804, with an exercise price of $1.03.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Pi Network News: PI Price Jumps 4% as Team Announces Three-Day Developer Summit
These Alts Bleed the Most as Bitcoin (BTC) Settles Below $82K: Weekend Watch
New York Fed warns: Service sector input and sales prices surge, significant price pressure
A survey by the New York Federal Reserve shows that service sector input costs and prices in October rose sharply, while the business activity index fell to its lowest level since March. Businesses have turned pessimistic about the outlook, with increasing inflation and interest rate pressures.
Crypto prices
More
